News | News By Subject | News by Disease News By Date | Search News

Parkinson's disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Acorda (ACOR) Jumps as Parkinson’s Drug Performs Well in Late-Stage Study     6/6/2017
Acorda (ACOR) Rockets After Parkinson's Drug Hits Late-Stage Goals     2/10/2017
Merck KGaA (MKGAF.PK) Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials     2/7/2017
Key Parkinson's Trial Delayed Due to Feud Between a Georgetown University Scientist and The Michael J. Fox Foundation     8/31/2016
Acadia (ACAD) Drug Approval May Make It an Attractive Target for Biogen (BIIB), Teva (TEVA)     5/9/2016
FDA Clears Acadia (ACAD)'s NUPLAZID, the First Drug for Psychosis Linked to Parkinson's     5/2/2016
Acorda (ACOR)'s Parkinson’s Candidate Meets Goal in Phase II Trial     4/20/2016
Acadia (ACAD) Surges as FDA Panel Backs Psychosis Drug Linked to Parkinson’s Disease     3/30/2016
FDA Staff Says Acadia (ACAD)'s Drug for Parkinson's Disease Psychosis Nuplazid is Effective     3/28/2016
Three Biotechs Cited as Promising Bets in 2016 With FDA Decisions Pending     2/22/2016
Acorda (ACOR) Bulks Up Parkinson's Pipeline with $363 Million Takeover of Biotie     1/20/2016
Adamas Pharmaceuticals (ADMS)' Lead Drug ADS-5102 Meets Phase III Goals; Stock Surges     12/28/2015
Novartis AG (NVS) Cancer Drug May Help Parkinson's Patients     10/19/2015
Exciting Time for Biotech in New Jersey     6/29/2015
Pfizer (PFE) Agrees to Pay Off Parkinson Patients Who Developed Gambling and Sex Addiction While On Cabaser     5/11/2015

News from Around the Web
Biofeedback Technology Helping Improve Balance In Parkinson's Patients, University of Houston Study     8/1/2017
CRISPR Tech Leads To New Screening Tool For Parkinson's Disease, University of Central Florida Reveals     6/7/2017
Researchers Develop New DBS Method With No Surgery, MIT Study     6/2/2017
A Watch Fights Tremors And Woman Finds Ability To Write, Microsoft Reveals     5/15/2017
To Probe Parkinson’s, Treat The Brain Like A Piece Of Electronics, Stanford University Study     1/30/2017
Parkinson's Linked To Gut Bacteria, California Institute of Technology Study     12/2/2016
How This Small Wearable Could Help Doctors Spot Parkinson's Earlier, University Politehnica Of Bucharest Study     9/16/2016
DNA Brain Injection Could Help Control Parkinson's Symptoms, Voyager Therapeutics (VYGR) Reveals     8/23/2016
Eye Test May Detect Parkinson’s Before Symptoms Appear, University College London Study     8/19/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
Cancer Drug Could Help Parkinson's, Dementia Patients, Georgetown University Study     7/14/2016
Detecting Parkinson’s Through A Urine Test, University of Alabama at Birmingham Study     7/8/2016
Blocking Key Enzyme Halts Parkinson's Disease Symptoms In Mice, Johns Hopkins University Study     6/29/2016
Pesticide-Linked Parkinson's Disease May Be Preventable, UCLA Scientists Reveal     6/16/2016
New Approaches To Early Identification Of Parkinson’s Disease     5/31/2016

Press Releases
Mount Tam Biotechnologies Announces Collaboration To Study Potential In Parkinson's Disease     7/28/2017
Isodiol International Receives Regulatory (ANVISA) Approval For Isoderm For The Treatment Of Epilepsy And Parkinson's     7/6/2017
Founders Of Philadelphia Biotech Enterin Discover Link Between Upper GI Tract Infections And Parkinson's Disease     6/29/2017
Parkinson's Disease Patients Are First To Be Treated With Elekta's New Leksell Vantage Stereotactic System     6/28/2017
Results Of NeuroDerm (NDRM)’s ND0612H Phase II Trial Presented In Oral Session At The 3rd Congress Of The European Academy Of Neurology     6/27/2017
Voyager Therapeutics (VYGR) Announces Clinical Trial Update With VY-AADC01 For Advanced Parkinson’s Disease     6/26/2017
Global Kinetics Corporation Big Data Highlights Unmet Needs & Global Variations In Parkinson's Disease     6/16/2017
Adamas Pharma (ADMS) Announces Publication Of ADS-5102 Phase III EASE LID Clinical Trial In JAMA Neurology     6/13/2017
Herantis Pharma's Clinical Study With CDNF In Parkinson's Disease Authorized In Finland, Company Expands On Development Plan     6/12/2017
The Michael J. Fox Foundation Launches Clinician Input Study In Parkinson's Disease To Evaluate Mobile Technology In Clinical Care     6/12/2017
Baylor College of Medicine Release: Anti-Alpha-Synuclein Antibody Is A Potential Disease-Modifying Treatment For Parkinson’s Disease     6/12/2017
International Parkinson And Movement Disorder Society Release: Smartphone Data Provide New Insight into Daily Functioning in Parkinson’s Disease     6/8/2017
NeuroDerm (NDRM) Presents Six Posters At The 21st International Congress Of Parkinson’s Disease And Movement Disorders     6/8/2017
AFFiRiS AG Announces Top Line Results Of First-In-Human Clinical Study Using AFFITOPE PD03A, Confirming Immunogenicity And Safety Profile In Parkinson's Disease Patients     6/7/2017
Juntendo University Research: Potential Therapeutic Target For Parkinson’s Disease     6/7/2017

//-->